Bristol Myers Squibb (CELG-RI) Other Working Capital Changes (2009 - 2026)

Bristol Myers Squibb has disclosed Other Working Capital Changes across 18 years of filings, most recently posting $1.6 billion for Q1 2026.

• In Q1 2026, Other Working Capital Changes rose 54.49% year-over-year to $1.6 billion; the TTM figure through Mar 2026 stood at $106.0 million (up 161.27% YoY), while the FY2025 annual figure was -$471.0 million, up 24.52% from the prior year.
• Other Working Capital Changes improved to $1.6 billion in Q1 2026, from -$1.1 billion in the prior quarter.
• Over the last five years, Other Working Capital Changes for CELG-RI reached as high as $1.6 billion in Q1 2026 and fell as low as -$1.1 billion in Q4 2025.
• The 5-year median for Other Working Capital Changes is -$167.0 million (2024), against an average of $106.9 million.
• Annual changes were most pronounced in 2022 — Other Working Capital Changes jumped 185.27% — and 2024, when it sank 383.05%.
• A 5-year view of Other Working Capital Changes shows it stood at -$700.0 million in 2022, then jumped by 59.57% to -$283.0 million in 2023, then sank by 156.18% to -$725.0 million in 2024, then tumbled by 47.31% to -$1.1 billion in 2025, then jumped by 253.18% to $1.6 billion in 2026.
• According to Business Quant data, Other Working Capital Changes over the past three periods registered $1.6 billion, -$1.1 billion, and -$240.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.